p27 modulates tropism of mesenchymal stem cells toward brain tumors

Yun Gao, Chunyu Gu, Shaoyi Li, Tsutomu Tokuyama, Naoki Yokota, Keiichi I. Nakayama, Masatoshi Kitagawa, Hiroki Namba

研究成果: ジャーナルへの寄稿記事

4 引用 (Scopus)

抄録

Mesenchymal stem cells (MSCs) have inherent tumor-tropic properties in the brain and seem to be a useful tool for cellular therapy for brain tumors. However, the mechanisms involved in MSC migration are not fully understood. The tumor suppressor p27, an inhibitor of cyclin-dependent kinase complexes, not only plays a crucial role in cell cycle regulation but also has cell cycle-independent functions, such as differentiation and migration of cells. In fact, p27 has been alternatively reported to inhibit or stimulate cell migration in cells of different types. Therefore, in the present study, we investigated whether p27 is involved in the tumor-tropic activity of MSCs using MSCs from p27-null mice. It was found that p27-/- MSCs showed a decreased motility in the wound healing assay and displayed increased numbers of stress fibers. To compare the in vivo migratory activity of p27-/- and p27+/+ MSCs toward glioma, we injected C6 glioma cells into one side of the mouse brain and BrdU-labeled p27-/- or p27+/+ MSCs into the other side. Significantly fewer labeled p27-/- MSCs were observed in the tumor area compared with p27+/+ MSCs. The present study suggests that p27 works as a stimulator of the in vitro and in vivo migration process of MSCs toward tumors. These findings are important when the efficacy of stem cell-based strategies for glioma therapy is considered.

元の言語英語
ページ(範囲)695-699
ページ数5
ジャーナルExperimental and Therapeutic Medicine
1
発行部数4
DOI
出版物ステータス出版済み - 7 1 2010

Fingerprint

Tropism
Mesenchymal Stromal Cells
Brain Neoplasms
Glioma
Cell Movement
Neoplasms
Cell Cycle
Cyclin-Dependent Kinase Inhibitor p27
Stress Fibers
Brain
Bromodeoxyuridine
Wound Healing
Cell Differentiation
Stem Cells

All Science Journal Classification (ASJC) codes

  • Immunology and Microbiology (miscellaneous)
  • Cancer Research

これを引用

p27 modulates tropism of mesenchymal stem cells toward brain tumors. / Gao, Yun; Gu, Chunyu; Li, Shaoyi; Tokuyama, Tsutomu; Yokota, Naoki; Nakayama, Keiichi I.; Kitagawa, Masatoshi; Namba, Hiroki.

:: Experimental and Therapeutic Medicine, 巻 1, 番号 4, 01.07.2010, p. 695-699.

研究成果: ジャーナルへの寄稿記事

Gao, Y, Gu, C, Li, S, Tokuyama, T, Yokota, N, Nakayama, KI, Kitagawa, M & Namba, H 2010, 'p27 modulates tropism of mesenchymal stem cells toward brain tumors', Experimental and Therapeutic Medicine, 巻. 1, 番号 4, pp. 695-699. https://doi.org/10.3892/etm_00000107
Gao, Yun ; Gu, Chunyu ; Li, Shaoyi ; Tokuyama, Tsutomu ; Yokota, Naoki ; Nakayama, Keiichi I. ; Kitagawa, Masatoshi ; Namba, Hiroki. / p27 modulates tropism of mesenchymal stem cells toward brain tumors. :: Experimental and Therapeutic Medicine. 2010 ; 巻 1, 番号 4. pp. 695-699.
@article{beab548eb1d24e9fb6050c875e743572,
title = "p27 modulates tropism of mesenchymal stem cells toward brain tumors",
abstract = "Mesenchymal stem cells (MSCs) have inherent tumor-tropic properties in the brain and seem to be a useful tool for cellular therapy for brain tumors. However, the mechanisms involved in MSC migration are not fully understood. The tumor suppressor p27, an inhibitor of cyclin-dependent kinase complexes, not only plays a crucial role in cell cycle regulation but also has cell cycle-independent functions, such as differentiation and migration of cells. In fact, p27 has been alternatively reported to inhibit or stimulate cell migration in cells of different types. Therefore, in the present study, we investigated whether p27 is involved in the tumor-tropic activity of MSCs using MSCs from p27-null mice. It was found that p27-/- MSCs showed a decreased motility in the wound healing assay and displayed increased numbers of stress fibers. To compare the in vivo migratory activity of p27-/- and p27+/+ MSCs toward glioma, we injected C6 glioma cells into one side of the mouse brain and BrdU-labeled p27-/- or p27+/+ MSCs into the other side. Significantly fewer labeled p27-/- MSCs were observed in the tumor area compared with p27+/+ MSCs. The present study suggests that p27 works as a stimulator of the in vitro and in vivo migration process of MSCs toward tumors. These findings are important when the efficacy of stem cell-based strategies for glioma therapy is considered.",
author = "Yun Gao and Chunyu Gu and Shaoyi Li and Tsutomu Tokuyama and Naoki Yokota and Nakayama, {Keiichi I.} and Masatoshi Kitagawa and Hiroki Namba",
year = "2010",
month = "7",
day = "1",
doi = "10.3892/etm_00000107",
language = "English",
volume = "1",
pages = "695--699",
journal = "Experimental and Therapeutic Medicine",
issn = "1792-0981",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - p27 modulates tropism of mesenchymal stem cells toward brain tumors

AU - Gao, Yun

AU - Gu, Chunyu

AU - Li, Shaoyi

AU - Tokuyama, Tsutomu

AU - Yokota, Naoki

AU - Nakayama, Keiichi I.

AU - Kitagawa, Masatoshi

AU - Namba, Hiroki

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Mesenchymal stem cells (MSCs) have inherent tumor-tropic properties in the brain and seem to be a useful tool for cellular therapy for brain tumors. However, the mechanisms involved in MSC migration are not fully understood. The tumor suppressor p27, an inhibitor of cyclin-dependent kinase complexes, not only plays a crucial role in cell cycle regulation but also has cell cycle-independent functions, such as differentiation and migration of cells. In fact, p27 has been alternatively reported to inhibit or stimulate cell migration in cells of different types. Therefore, in the present study, we investigated whether p27 is involved in the tumor-tropic activity of MSCs using MSCs from p27-null mice. It was found that p27-/- MSCs showed a decreased motility in the wound healing assay and displayed increased numbers of stress fibers. To compare the in vivo migratory activity of p27-/- and p27+/+ MSCs toward glioma, we injected C6 glioma cells into one side of the mouse brain and BrdU-labeled p27-/- or p27+/+ MSCs into the other side. Significantly fewer labeled p27-/- MSCs were observed in the tumor area compared with p27+/+ MSCs. The present study suggests that p27 works as a stimulator of the in vitro and in vivo migration process of MSCs toward tumors. These findings are important when the efficacy of stem cell-based strategies for glioma therapy is considered.

AB - Mesenchymal stem cells (MSCs) have inherent tumor-tropic properties in the brain and seem to be a useful tool for cellular therapy for brain tumors. However, the mechanisms involved in MSC migration are not fully understood. The tumor suppressor p27, an inhibitor of cyclin-dependent kinase complexes, not only plays a crucial role in cell cycle regulation but also has cell cycle-independent functions, such as differentiation and migration of cells. In fact, p27 has been alternatively reported to inhibit or stimulate cell migration in cells of different types. Therefore, in the present study, we investigated whether p27 is involved in the tumor-tropic activity of MSCs using MSCs from p27-null mice. It was found that p27-/- MSCs showed a decreased motility in the wound healing assay and displayed increased numbers of stress fibers. To compare the in vivo migratory activity of p27-/- and p27+/+ MSCs toward glioma, we injected C6 glioma cells into one side of the mouse brain and BrdU-labeled p27-/- or p27+/+ MSCs into the other side. Significantly fewer labeled p27-/- MSCs were observed in the tumor area compared with p27+/+ MSCs. The present study suggests that p27 works as a stimulator of the in vitro and in vivo migration process of MSCs toward tumors. These findings are important when the efficacy of stem cell-based strategies for glioma therapy is considered.

UR - http://www.scopus.com/inward/record.url?scp=80855143980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80855143980&partnerID=8YFLogxK

U2 - 10.3892/etm_00000107

DO - 10.3892/etm_00000107

M3 - Article

AN - SCOPUS:80855143980

VL - 1

SP - 695

EP - 699

JO - Experimental and Therapeutic Medicine

JF - Experimental and Therapeutic Medicine

SN - 1792-0981

IS - 4

ER -